Delivery Order SPE2DB24D1104-SPE2DB24FXVC1

Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $44,704.89 Firm Fixed Price Delivery Order is for the supply of the medication Isentress 400 mg tablets. The contract has an ultimate completion date of October 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,236.60 firm fixed-price delivery order covers the procurement of Isentress 400mg tablets, with an ultimate completion date of May 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,441.51 firm fixed-price contract is for the supply of the pharmaceutical product Isentress 400 mg tablets. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,584.55 for the supply of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order worth $25,347.67 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablet medications. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a wide range of essential pharmaceutical and medical supplies to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, worth $1,288.10, is for the delivery of the pharmaceutical product Isentress 400 mg Tablet 60s. The award has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously received...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,373.67, is for the delivery of Isentress 400 mg tablets over a period ending on July 17, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division will be...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,394.44 and is for the delivery of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a final completion date of January 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $4,740.96 firm fixed-price delivery order is for the supply of Isentress 400 mg tablets, a prescription medication used to treat HIV infection. The contract has an ultimate completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,509.22 firm fixed-price delivery order is for the supply of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product, with a performance period through October 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FXVC1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Isentress 400 mg tablets. The contract has a ceiling value of $1,282.19 and a period of performance ending on March 7, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen's expertise in pharmaceutical distribution and its extensive supply chain network have allowed the company to secure numerous federal contract awards for supplying critical medical products to various government agencies, including the Department of Defense and Veterans Affairs healthcare systems.

Generated 7/18/24, 9:44 AM